Caly, Hugues
Rabiei, Hamed
Coste-Mazeau, Perrine
Hantz, Sebastien
Alain, Sophie
Eyraud, Jean-Luc
Chianea, Thierry
Caly, Catherine
Makowski, David
Hadjikhani, Nouchine
Lemonnier, Eric
Ben-Ari, Yehezkel
Article History
Received: 10 August 2020
Accepted: 10 March 2021
First Online: 25 March 2021
Competing interests
: Dr. S. Alain reported being a Scientific Expert for GSK, Shire, Sanofi, MSD, Merck, Biotest, BioMérieux and Hologic, and IP France Solstice study (Takeda). Dr. Y. Ben-Ari reported being the CEO and shareholder of BABiomedical, a company dedicated to the use of artificial intelligence in biomedical research, and Neurochlore, a company dedicated to treat autism. Dr. S. Hantz reported receiving a congress fee, travel and accommodation by MSD vaccines, a congress fee from Diasorin, and a remuneration as speaker for “Expert days in virology” from Roche Diagnostics. Dr. E. Lemonnier reported being a shareholder of Neurochlore. Dr. H. Rabiei reported his salary is paid by Neurochlore and BABiomedical company. Dr. N. Hadjikhani reported that she is a shareholder of Neurochlore. The other authors (P. Coste-Mazeau, T. Chianea, J-L Eyraud, H. Caly, C. Caly and D. Makowski) have no competing interests.